BlossomHill Therapeutics
Evan Rogers is currently serving as the Sr. Director of Chemistry at BlossomHill Therapeutics, Inc. Previously, Evan held positions such as Director of Chemistry and Senior Principal Scientist at Turning Point Therapeutics. With a background in total synthesis, development of analytical methods, and management of analytical laboratories, Evan has a strong scientific and technical expertise. From leading teams to conducting unique experiments to supporting biological testing, Evan's experience spans across academia, government, and industry, making them a versatile and valuable asset in the field of chemistry.
BlossomHill Therapeutics
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders.